| MeSH term | MeSH ID | Detail |
|---|---|---|
| Bone Cysts, Aneurysmal | D017824 | 2 associated lipids |
| Bone Diseases, Developmental | D001848 | 2 associated lipids |
| Actinomycosis | D000196 | 2 associated lipids |
| Fractures, Stress | D015775 | 2 associated lipids |
| Osteosclerosis | D010026 | 2 associated lipids |
| Osteophyte | D054850 | 2 associated lipids |
| Carcinoma, Neuroendocrine | D018278 | 2 associated lipids |
| Pericardial Effusion | D010490 | 2 associated lipids |
| Lymphocytosis | D008218 | 2 associated lipids |
| Prenatal Exposure Delayed Effects | D011297 | 2 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Park K et al. | Increased OPG/RANKL ratio in the conditioned medium of soybean-treated osteoblasts suppresses RANKL-induced osteoclast differentiation. | 2014 | Int. J. Mol. Med. | pmid:24248634 |
| El-Hoss J et al. | Modulation of endochondral ossification by MEK inhibitors PD0325901 and AZD6244 (Selumetinib). | 2014 | Bone | pmid:24269278 |
| Steffens JP et al. | Testosterone regulates bone response to inflammation. | 2014 | Horm. Metab. Res. | pmid:24526374 |
| Dumnicka P et al. | Osteoprotegerin, trail and osteoprotegerin/trail ratio in patients at early phase of acute pancreatitis. | 2014 | Folia Med Cracov | pmid:25648306 |
| Nascimento MM et al. | Elevated levels of plasma osteoprotegerin are associated with all-cause mortality risk and atherosclerosis in patients with stages 3 to 5 chronic kidney disease. | 2014 | Braz. J. Med. Biol. Res. | pmid:25296363 |
| Yokota K et al. | Combination of tumor necrosis factor α and interleukin-6 induces mouse osteoclast-like cells with bone resorption activity both in vitro and in vivo. | 2014 | pmid:24431283 | |
| Polyzos SA et al. | Denosumab treatment for juvenile Paget's disease: results from two adult patients with osteoprotegerin deficiency ("Balkan" mutation in the TNFRSF11B gene). | 2014 | J. Clin. Endocrinol. Metab. | pmid:24433001 |
| Zhou DA et al. | Influence of glucocorticoids on the osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. | 2014 | BMC Musculoskelet Disord | pmid:25027542 |
| Marques EA et al. | Response of bone mineral density, inflammatory cytokines, and biochemical bone markers to a 32-week combined loading exercise programme in older men and women. | 2013 Sep-Oct | Arch Gerontol Geriatr | pmid:23623588 |
| Liu S et al. | Association between g.19163A>G and g.23298T>C genetic variants of the osteoprotegerin gene and bone mineral density in Chinese women. | 2013 Oct-Dec | Hormones (Athens) | pmid:24457406 |
| Chiang PH et al. | Zoledronic acid treatment for cancerous bone metastases: a phase IV study in Taiwan. | 2013 Oct-Dec | J Cancer Res Ther | pmid:24518712 |
| Canto-Cetina T et al. | Polymorphism of LRP5, but not of TNFRSF11B, is associated with a decrease in bone mineral density in postmenopausal Maya-Mestizo women. | 2013 Nov-Dec | Am. J. Hum. Biol. | pmid:24130145 |
| Horshuns'ka MIu et al. | [Biological role of fetuin A and its potential importance for prediction of cardiovascular risk in patients with type 2 diabetes mellitus]. | 2013 May-Jun | Ukr Biokhim Zh (1999) | pmid:23937044 |
| Zamora PO et al. | Biocompatibility and inflammation profile of B2A-coated granules used in arthrodesis. | 2013 Mar-Apr | Int. J. Toxicol. | pmid:23422080 |
| Esteghamati A et al. | Comparison of osteoprotegerin and vascular endothelial growth factor in normoalbuminuric Type 1 diabetic and control subjects. | 2013 Jul-Aug | J. Endocrinol. Invest. | pmid:23877020 |
| Glintborg D et al. | Plasma osteoprotegerin is associated with testosterone levels but unaffected by pioglitazone treatment in patients with polycystic ovary syndrome. | 2013 Jul-Aug | J. Endocrinol. Invest. | pmid:23211475 |
| Nanjundaiah SM et al. | Kinetics and interplay of mediators of inflammation-induced bone damage in the course of adjuvant arthritis. | 2013 Jan-Mar | Int J Immunopathol Pharmacol | pmid:23527707 |
| Pichler K et al. | RANKL is downregulated in bone cells by physical activity (treadmill and vibration stimulation training) in rat with glucocorticoid-induced osteoporosis. | 2013 | Histol. Histopathol. | pmid:23553492 |
| Tantikanlayaporn D et al. | A diarylheptanoid phytoestrogen from Curcuma comosa, 1,7-diphenyl-4,6-heptadien-3-ol, accelerates human osteoblast proliferation and differentiation. | 2013 | Phytomedicine | pmid:23557993 |
| Rahnama M et al. | Influence of hormone replacement therapy on osteoprotegerin and receptor activator of nuclear factor kappa-B ligand concentrations in menopausal women. | 2013 | J. Interferon Cytokine Res. | pmid:23745763 |
| Fuernau G et al. | Osteoprotegerin in ST-elevation myocardial infarction: prognostic impact and association with markers of myocardial damage by magnetic resonance imaging. | 2013 | Int. J. Cardiol. | pmid:22704876 |
| Danks L and Takayanagi H | Immunology and bone. | 2013 | J. Biochem. | pmid:23750028 |
| Tao H et al. | OPG/RANK/RANKL axis as a potential therapeutic target for atrial fibrillation. | 2013 | Cardiology | pmid:23751957 |
| Rakic M et al. | Bone loss biomarkers associated with peri-implantitis. A cross-sectional study. | 2013 | Clin Oral Implants Res | pmid:22708989 |
| Xi L et al. | OPG/RANK/RANKL axis in atrial fibrillation. | 2013 | Cardiology | pmid:23752030 |
| Ostrowska Z et al. | Assessment of the relationship between melatonin, hormones of the pituitary-ovarian, -thyroid and -adrenocortical axes, and osteoprotegerin and its ligand sRANKL in girls with anorexia nervosa. | 2013 | Postepy Hig Med Dosw (Online) | pmid:23752595 |
| Uehara H et al. | Induction of retinol-binding protein 4 and placenta-specific 8 expression in human prostate cancer cells remaining in bone following osteolytic tumor growth inhibition by osteoprotegerin. | 2013 | Int. J. Oncol. | pmid:23708710 |
| Zhu Y et al. | Deciduous dental pulp stem cells are involved in osteoclastogenesis during physiologic root resorption. | 2013 | J. Cell. Physiol. | pmid:22674471 |
| Okamura H et al. | Protein phosphatase 2A Cα is involved in osteoclastogenesis by regulating RANKL and OPG expression in osteoblasts. | 2013 | FEBS Lett. | pmid:23183242 |
| Silva HC et al. | Higher prevalence of morphometric vertebral fractures in patients with recent coronary events independently of BMD measurements. | 2013 | Bone | pmid:23142805 |
| Sivagurunathan S et al. | Thrombin inhibits osteoclast differentiation through a non-proteolytic mechanism. | 2013 | J. Mol. Endocrinol. | pmid:23419317 |
| Ai LS et al. | Gene silencing of the BDNF/TrkB axis in multiple myeloma blocks bone destruction and tumor burden in vitro and in vivo. | 2013 | Int. J. Cancer | pmid:23420490 |
| Koide M et al. | Osteoprotegerin-deficient male mice as a model for severe alveolar bone loss: comparison with RANKL-overexpressing transgenic male mice. | 2013 | Endocrinology | pmid:23291450 |
| Pacifici R | Osteoimmunology and its implications for transplantation. | 2013 | Am. J. Transplant. | pmid:23915249 |
| Albu A et al. | Bone metabolism regulators and arterial stiffness in postmenopausal women. | 2013 | Maturitas | pmid:23916080 |
| Panzarini SR et al. | Histological and immunohistochemical analyses of the chronology of healing process after immediate tooth replantation in incisor rat teeth. | 2013 | Dent Traumatol | pmid:22413942 |
| Bauer S et al. | Early detection of bone metabolism changes under different antiepileptic drugs (ED-BoM-AED)--a prospective multicenter study. | 2013 | Epilepsy Res. | pmid:23916144 |
| Nile CJ et al. | Comparison of circulating tumour necrosis factor superfamily cytokines in periodontitis patients undergoing supportive therapy: a case-controlled cross-sectional study comparing smokers and non-smokers in health and disease. | 2013 | J. Clin. Periodontol. | pmid:23919740 |
| O'Sullivan EP et al. | A comparison of osteoprotegerin with adiponectin and high-sensitivity C-reactive protein (hsCRP) as a marker for insulin resistance. | 2013 | Metab. Clin. Exp. | pmid:22841521 |
| Loiselle AE et al. | Inhibition of GSK-3β rescues the impairments in bone formation and mechanical properties associated with fracture healing in osteoblast selective connexin 43 deficient mice. | 2013 | PLoS ONE | pmid:24260576 |
| Fekete S et al. | The effect of levetiracetam on rat bone mass, structure and metabolism. | 2013 | Epilepsy Res. | pmid:24035343 |
| He T et al. | Multiple biomarkers analysis for the early detection of prosthetic aseptic loosening of hip arthroplasty. | 2013 | Int Orthop | pmid:23467893 |
| Song JF et al. | Association between single nucleotide polymorphisms of the osteoprotegerin gene and postmenopausal osteoporosis in Chinese women. | 2013 | Genet. Mol. Res. | pmid:24065669 |
| Lin C et al. | The C-terminal region Mesd peptide mimics full-length Mesd and acts as an inhibitor of Wnt/β-catenin signaling in cancer cells. | 2013 | PLoS ONE | pmid:23469146 |
| Yu F et al. | Association between osteoprotegerin genetic variants and osteoporosis in Chinese postmenopausal women. | 2013 | Endocr. J. | pmid:24067544 |
| Wu LZ et al. | Nicotine favors osteoclastogenesis in human periodontal ligament cells co-cultured with CD4(+) T cells by upregulating IL-1β. | 2013 | Int. J. Mol. Med. | pmid:23443505 |
| Mazière C et al. | Oxidized low density lipoprotein increases RANKL level in human vascular cells. Involvement of oxidative stress. | 2013 | Biochem. Biophys. Res. Commun. | pmid:24070606 |
| Nishigaki M et al. | β-cryptoxanthin regulates bone resorption related-cytokine production in human periodontal ligament cells. | 2013 | Arch. Oral Biol. | pmid:23452546 |
| He JY et al. | Sympathetic neuron can promote osteoblast differentiation through BMP signaling pathway. | 2013 | Cell. Signal. | pmid:23454096 |
| Benito-Martin A et al. | Osteoprotegerin in exosome-like vesicles from human cultured tubular cells and urine. | 2013 | PLoS ONE | pmid:24058411 |
| Yu J et al. | Effect of fluoride and low versus high levels of dietary calcium on mRNA expression of osteoprotegerin and osteoprotegerin ligand in the bone of rats. | 2013 | Biol Trace Elem Res | pmid:23456427 |
| Lau CP et al. | Comparison of the anti-tumor effects of denosumab and zoledronic acid on the neoplastic stromal cells of giant cell tumor of bone. | 2013 | Connect. Tissue Res. | pmid:24060052 |
| Corrado A et al. | RANKL/OPG ratio and DKK-1 expression in primary osteoblastic cultures from osteoarthritic and osteoporotic subjects. | 2013 | J. Rheumatol. | pmid:23457386 |
| Koluman BU et al. | Association between osteoprotegerin, fetuin-A, carotid intima media thickness, and urinary albumin excretion in Type 2 diabetes. | 2013 | Clin. Nephrol. | pmid:23458176 |
| Kuo PL et al. | MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein. | 2013 | Biochim. Biophys. Acta | pmid:23458685 |
| Asanuma YF et al. | Serum osteoprotegerin concentration is associated with carotid atherosclerotic plaque in patients with rheumatoid arthritis. | 2013 | Mod Rheumatol | pmid:22584471 |
| Sooampon S et al. | Transient receptor potential vanilloid-1 regulates osteoprotegerin/RANKL homeostasis in human periodontal ligament cells. | 2013 | J. Periodont. Res. | pmid:22587561 |
| Galli C et al. | GSK3b-inhibitor lithium chloride enhances activation of Wnt canonical signaling and osteoblast differentiation on hydrophilic titanium surfaces. | 2013 | Clin Oral Implants Res | pmid:22626030 |
| Jiang W et al. | Identification of five serum protein markers for detection of ovarian cancer by antibody arrays. | 2013 | PLoS ONE | pmid:24116163 |
| Canalis E et al. | Notch signaling in osteocytes differentially regulates cancellous and cortical bone remodeling. | 2013 | J. Biol. Chem. | pmid:23884415 |
| Szymczak J and Bohdanowicz-Pawlak A | Osteoprotegerin, RANKL, and bone turnover in primary hyperparathyroidism: the effect of parathyroidectomy and treatment with alendronate. | 2013 | Horm. Metab. Res. | pmid:23888411 |
| Gordin D et al. | Osteoprotegerin is an independent predictor of vascular events in Finnish adults with type 1 diabetes. | 2013 | Diabetes Care | pmid:23801795 |
| Fu YX et al. | Inhibitory effects of osteoprotegerin on osteoclast formation and function under serum-free conditions. | 2013 | J. Vet. Sci. | pmid:23820214 |
| Baud'huin M et al. | Osteoprotegerin: multiple partners for multiple functions. | 2013 | Cytokine Growth Factor Rev. | pmid:23827649 |
| Wang Q et al. | The relationship between osteoprotegerin gene polymorphisms and bone mineral density in Chinese postmenopausal women. | 2013 | Int. Immunopharmacol. | pmid:23856613 |
| Mogi M and Kondo A | The presence of RANKL-OPG complex in human osteosarcoma U2OS. | 2013 | J Immunoassay Immunochem | pmid:23859786 |
| Zappitelli T et al. | The G60S connexin 43 mutation activates the osteoblast lineage and results in a resorption-stimulating bone matrix and abrogation of old-age-related bone loss. | 2013 | J. Bone Miner. Res. | pmid:23606335 |
| Kao SY et al. | Loss of osteoprotegerin expression in the inner ear causes degeneration of the cochlear nerve and sensorineural hearing loss. | 2013 | Neurobiol. Dis. | pmid:23607938 |
| Eleftheriadis T et al. | Serum osteoprotegerin is markedly increased and may contribute to decreased blood T cell count in hemodialysis patients. | 2013 | Int Urol Nephrol | pmid:23296793 |
| dos Santos PL et al. | Guided implant surgery: what is the influence of this new technique on bone cell viability? | 2013 | J. Oral Maxillofac. Surg. | pmid:23298799 |
| Hoy J et al. | Interruption or deferral of antiretroviral therapy reduces markers of bone turnover compared with continuous therapy: The SMART body composition substudy. | 2013 | J. Bone Miner. Res. | pmid:23299909 |
| Zhou J et al. | [Effect of sinusoidal electromagnetic fields on rats femur tissue cultivation in vitro]. | 2013 | Sheng Wu Yi Xue Gong Cheng Xue Za Zhi | pmid:23865319 |
| Yassuda DH et al. | Magnesium incorporation into β-TCP reduced its in vivo resorption by decreasing parathormone production. | 2013 | J Biomed Mater Res A | pmid:23239606 |
| Gao L et al. | Resolvin E1 and chemokine-like receptor 1 mediate bone preservation. | 2013 | J. Immunol. | pmid:23241890 |
| Brabnikova Maresova K et al. | Acute effects of glucocorticoids on serum markers of osteoclasts, osteoblasts, and osteocytes. | 2013 | Calcif. Tissue Int. | pmid:23247536 |
| Eren MA et al. | Association of parity with osteoprotegerin levels and atherosclerosis. | 2013 | Arch. Gynecol. Obstet. | pmid:23287888 |
| Kim SJ et al. | Compressive stress induced the up-regulation of M-CSF, RANKL, TNF-α expression and the down-regulation of OPG expression in PDL cells via the integrin-FAK pathway. | 2013 | Arch. Oral Biol. | pmid:23219295 |
| Kanzaki H et al. | Mutations in K-Ras linked to levels of osteoprotegerin and sensitivity to TRAIL-induced cell death in pancreatic ductal adenocarcinoma cells. | 2013 | Exp. Mol. Pathol. | pmid:23219833 |
| Wang H et al. | Combination gene therapy targeting on interleukin-1β and RANKL for wear debris-induced aseptic loosening. | 2013 | Gene Ther. | pmid:22318091 |
| Kebschull M et al. | Mobilization of endothelial progenitors by recurrent bacteremias with a periodontal pathogen. | 2013 | PLoS ONE | pmid:23355901 |
| Velusamy SK et al. | Lactoferrin knockout mice demonstrates greater susceptibility to Aggregatibacter actinomycetemcomitans-induced periodontal disease. | 2013 | J. Periodontol. | pmid:23327622 |
| Gümüş P et al. | Gingival crevicular fluid, serum levels of receptor activator of nuclear factor-κB ligand, osteoprotegerin, and interleukin-17 in patients with rheumatoid arthritis and osteoporosis and with periodontal disease. | 2013 | J. Periodontol. | pmid:23327689 |
| Rosenheck S | The heart and the osteoclasts. | 2013 | Cardiology | pmid:23328209 |
| Ko GJ | A biomarker, osteoprotegerin, in patients undergoing hemodialysis. | 2013 | Korean J. Intern. Med. | pmid:24307839 |
| Lee JE et al. | Serum osteoprotegerin is associated with vascular stiffness and the onset of new cardiovascular events in hemodialysis patients. | 2013 | Korean J. Intern. Med. | pmid:24307842 |
| Frederiksen L et al. | Osteoprotegerin levels decrease during testosterone therapy in aging men and are associated with changed distribution of regional fat. | 2013 | Horm. Metab. Res. | pmid:22918704 |
| Hartwich JE et al. | Rapamycin increases neuroblastoma xenograft and host stromal derived osteoprotegerin inhibiting osteolytic bone disease in a bone metastasis model. | 2013 | J. Pediatr. Surg. | pmid:23331792 |
| Naidu VG et al. | RANKL targeted peptides inhibit osteoclastogenesis and attenuate adjuvant induced arthritis by inhibiting NF-κB activation and down regulating inflammatory cytokines. | 2013 | Chem. Biol. Interact. | pmid:23333834 |
| Yao Y et al. | Combination of MTX and LEF attenuates inflammatory bone erosion by down-regulation of receptor activator of NF-kB ligand and interleukin-17 in type II collagen-induced arthritis rats. | 2013 | Rheumatol. Int. | pmid:23334376 |
| Zhang F et al. | Association analyses of osteoprotegerin gene polymorphisms with bone mineral density in Chinese postmenopausal women. | 2013 | Med. Oncol. | pmid:23335067 |
| Guerra-Menéndez L et al. | IGF-I increases markers of osteoblastic activity and reduces bone resorption via osteoprotegerin and RANK-ligand. | 2013 | J Transl Med | pmid:24161214 |
| MacNee W | Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease. | 2013 | Ann. Med. | pmid:23110517 |
| Montagnana M et al. | The role of osteoprotegerin in cardiovascular disease. | 2013 | Ann. Med. | pmid:23110639 |
| Romagnoli C et al. | Role of GSH/GSSG redox couple in osteogenic activity and osteoclastogenic markers of human osteoblast-like SaOS-2 cells. | 2013 | FEBS J. | pmid:23176170 |
| Kadkhodazadeh M et al. | Analysis of RANKL gene polymorphism (rs9533156 and rs2277438) in Iranian patients with chronic periodontitis and periimplantitis. | 2013 | Arch. Oral Biol. | pmid:23177932 |
| Barbieri G et al. | Biochemical markers of bone metabolism in gingival crevicular fluid during early orthodontic tooth movement. | 2013 | Angle Orthod | pmid:22716279 |
| Mercatali L et al. | RANK/RANK-L/OPG in patients with bone metastases treated with anticancer agents and zoledronic acid: a prospective study. | 2013 | Int J Mol Sci | pmid:23702841 |
| Braun T et al. | Mitogen-activated protein kinase 2 regulates physiological and pathological bone turnover. | 2013 | J. Bone Miner. Res. | pmid:23169443 |
| Bosselut N et al. | Including osteoprotegerin and collagen IV in a score-based blood test for liver fibrosis increases diagnostic accuracy. | 2013 | Clin. Chim. Acta | pmid:23022619 |
| Tousoulis D et al. | Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease. | 2013 | Int. J. Cardiol. | pmid:22640692 |